Welcome to LookChem.com Sign In|Join Free

CAS

  • or

60696-83-5

Post Buying Request

60696-83-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60696-83-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 60696-83-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,6,9 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 60696-83:
(7*6)+(6*0)+(5*6)+(4*9)+(3*6)+(2*8)+(1*3)=145
145 % 10 = 5
So 60696-83-5 is a valid CAS Registry Number.

60696-83-5Relevant articles and documents

Thermomorphic phase separation in ionic liquid-organic liquid systems - Conductivity and spectroscopic characterization

Riisager, Anders,Fehrmann, Rasmus,Berg, Rolf W.,Van Hal, Roy,Wasserscheid, Peter

, p. 3052 - 3058 (2005)

Electrical conductivity, FT-Raman and NMR measurements are demonstrated as useful tools to probe and determine phase behavior of thermomorphic ionic liquid-organic liquid systems. To illustrate the methods, consecutive conductivity measurements of a thermomorphic methoxyethoxyethyl-imidazolium ionic liquid/ 1-hexanol system are performed in the temperature interval 25-80°C using a specially constructed double-electrode cell. In addition. FT-Raman and 1H-NMR spectroscopic studies performed on the phase-separable system in the same temperature interval confirm the mutual solubility of the components in the system, the liquid liquid equilibrium phase diagram of the binary mixture, and signify the importance of hydrogen bonding between the ionic liquid and the hydroxyl group of the alcohol. The Owner Societies 2005.

2-PHENYLIMIDAZO[4,5-B]PYRIDIN-7-AMINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY

-

Page/Page column 93-94, (2018/03/26)

Compound of formula (I′) or (I′′) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.

SILICON PHTHALOCYANINE COMPLEX, PREPARATION METHOD AND MEDICINAL APPLICATION THEREOF

-

Paragraph 0166; 0167, (2017/01/26)

The present invention relates to a silicon phthalocyanine complex, the preparation method and the medicinal application thereof. The present invention particularly relates to a silicon phthalocyanine complex of formula (I), the preparation method thereof and a pharmaceutical composition comprising the same, as well as the use thereof as a photosensitizer, in particular the use in the treatment of cancers, wherein each substituent in formula (I) is the same as defined in the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60696-83-5